Skip to content
healthcare.dev

male balance

NDC 69779-008, Centarium umbellatum, flos, Ceratostigma willmottianum, flos, Kali Phos, Larix decidua, flos, Lycopodium, Nat Mur, Nat Phos, Silicea, spray, from Siddha Flower Essences LLC.

Product NDC
69779-008
Status
Listed
Labeler
Siddha Flower Essences LLC
Dosage form
SPRAY
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69779-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CENTAURIUM ERYTHRAEA FLOWER5 [hp_X]/29.6mL
  • CERATOSTIGMA WILLMOTTIANUM FLOWER5 [hp_X]/29.6mL
  • POTASSIUM PHOSPHATE, DIBASIC6 [hp_X]/29.6mL
  • LARIX DECIDUA FLOWERING TOP5 [hp_X]/29.6mL
  • LYCOPODIUM CLAVATUM SPORE6 [hp_C]/29.6mL
  • SODIUM CHLORIDE6 [hp_X]/29.6mL
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE6 [hp_X]/29.6mL
  • SILICON DIOXIDE12 [hp_X]/29.6mL

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
69779-008-01697790008011 BOTTLE in 1 CARTON (69779-008-01) / 29.6 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69779-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69779-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69779-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.